NU
Nuwellis, Inc.
NUWE · NASDAQ
$0.83 -3.81% (-$0.03)
1M -21.30%
Market Cap $76.2K
P/E Ratio -
Div. Yield -
ROE 605.75%
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 0.01x
P/FCF N/A
P/B N/A
Growth
12 /100
Declining Book val. growth 40.34%
Rev. growth 1.08%
FCF growth N/A
Profitability
20 /100
Weak FCF margin 139.68%
Op. margin 140.62%
Gross margin 69.69%
Quality
12 /100
Poor Asset turnover 0.99x
ROA 121.85%
ROIC 238.77%
Debt
99 /100
Low Current ratio 1.97x
Debt/Assets N/A
Net debt/EBITDA N/A
Stability
36 /100
Moderate Profitable years 0
EPS volatility 179.11%
Beta 0.29x
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na NUWE
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Michael McCormick
Employees
38
Headquarters
Eden Prairie
Nadcházející události
11 LIS
Earnings
Upcoming earnings report